Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Australia
  4. Australian Stock Exchange
  5. Healius Limited
  6. Summary
    HLS   AU0000033359

HEALIUS LIMITED

(HLS)
  Report
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Australian Stock Exchange
12/02/2021 12/03/2021 12/06/2021 12/07/2021 12/08/2021 Date
4.73 4.64 4.62 4.75 4.83 Last
2599946 1819655 1603264 2558296 3004320 Volume
-0.84% -1.90% -0.43% +2.81% +1.68% Change
Estimated financial data (e)
Sales 2022 2 303 M 1 649 M 1 649 M
Net income 2022 286 M 205 M 205 M
Net Debt 2022 41,8 M 30,0 M 30,0 M
P/E ratio 2022 9,91x
Yield 2022 4,67%
Sales 2023 1 968 M 1 409 M 1 409 M
Net income 2023 143 M 102 M 102 M
Net cash position 2023 45,5 M 32,6 M 32,6 M
P/E ratio 2023 20,1x
Yield 2023 3,45%
Capitalization 2 817 M 2 020 M 2 017 M
EV / Sales 2022 1,24x
EV / Sales 2023 1,41x
Nbr of Employees 11 000
Free-Float 86,4%
More Financials
Company
Healius Limited is an Australia-based healthcare company. The Company operates through three segments: Pathology, Imaging and Day Hospitals. Pathology segment provides pathology services. Imaging segment offers imaging and scanning services from imaging sites, hospitals and from within the consolidated entity's medical centers. Day Hospitals segment is an operator of day hospitals and hematology or oncology services... 
More about the company
Ratings of Healius Limited
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B-
More Ratings
All news about HEALIUS LIMITED
11/22HEALIUS : Notification regarding unquoted securities - HLS
PU
10/21THE WRAP : Stagflation? Asian Savings Slump, Insurers & Healthcare
AQ
10/15VIRTUS HEALTH : Federal Court Delays Virtus Health's Acquisition of Fertility Clinic Chain
MT
10/13VIRTUS HEALTH : ACCC seeks urgent injunction to halt Virtus acquiring Adora fertility clin..
AQ
10/12Virtus Says Regulator Seeking to Hold Up Acquisition of Healius Assets
DJ
09/13HEALIUS LIMITED : Ex-dividend day for final dividend
FA
08/29HEALIUS : Swings to FY21 Profit as Revenue Grows; Shares Down 7%
MT
08/29Healius Limited Announces Franked Distribution for the Period of Six Months Ended June ..
CI
08/29Healius Limited Reports Earnings Results for the Full Year Ended June 30, 2021
CI
08/29Tranche Update on Healius Limited's Equity Buyback Plan announced on December 9, 2020.
CI
07/12Healius Limited acquired Axis Diagnostic Holdings Pty Limited.
CI
07/01Healius Reportedly to Sale Day Surgeries
CI
05/17WHO ARE THE REAL CUSTOMERS OF GP COR : Doctors or patients?
AQ
04/20HEALIUS : Daily share buy-back notice - Appendix 3E - HLS
PU
04/19HEALIUS : Daily share buy-back notice - Appendix 3E - HLS
PU
More news
News in other languages on HEALIUS LIMITED
10/15La Cour fédérale retarde l'acquisition par Virtus Health d'une chaîne de cliniques de f..
08/29Healius réalise un bénéfice pour l'exercice 21 grâce à la croissance de son chiffre d'a..
08/29Healius Limited annonce une distribution franche pour la période de six mois se termina..
04/19Orocobre y Galaxy crearán nueva minera de litio de US$3.060m
04/19Orocobre et Galaxy Resources concluent un accord de fusion d'égaux de 3 milliards de do..
More news
Chart HEALIUS LIMITED
Duration : Period :
Healius Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends HEALIUS LIMITED
Short TermMid-TermLong Term
TrendsNeutralNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 13
Last Close Price 4,83 AUD
Average target price 5,21 AUD
Spread / Average Target 7,77%
EPS Revisions
Managers and Directors
Malcolm Parmenter Chief Executive Officer, MD & Director
Maxine Jaquet Chief Financial & Operating Officer
Robert Hubbard Independent Non-Executive Chairman
Paul Francis Jones Independent Non-Executive Director
Gordon R. Davis Independent Non-Executive Director
Sector and Competitors